{"id":2162,"date":"2017-10-16T09:06:20","date_gmt":"2017-10-16T08:06:20","guid":{"rendered":"https:\/\/futurehealthbiobank.com\/pt\/?p=2162"},"modified":"2021-07-28T14:46:02","modified_gmt":"2021-07-28T13:46:02","slug":"uma-possivel-cura-para-a-doenca-cardiaca","status":"publish","type":"post","link":"https:\/\/futurehealthbiobank.com\/pt\/noticias\/uma-possivel-cura-para-a-doenca-cardiaca\/","title":{"rendered":"C\u00e9lulas estaminais do cord\u00e3o umbilical: uma poss\u00edvel cura para a doen\u00e7a card\u00edaca"},"content":{"rendered":"

A new study published in <\/span><\/span>Circulation Research<\/span><\/span><\/a> by the American Heart Association demonstrates that cord blood stem cells can be used to treat heart disease.<\/span><\/span><\/h3>\n

<\/p>\n

This unique study demonstrated that stem cells increase cardiac muscle functionality in patients with <\/span><\/span>heart failure<\/span><\/span><\/a> .<\/span><\/span><\/p>\n

Thirty patients aged between 18 and 75 years (all with stable heart failure) were tested using either an IV Infusion of umbilical cord stem cells or a placebo for comparison. <\/span>All stem cells were taken from healthy human placentas during caesarean section. <\/span>The person responsible for the study, Fernando Figueroa, commented on the findings.<\/span><\/span><\/p>\n

We are encouraged by our findings, as they can pave the way for a promising new non-invasive therapy for a group of patients facing difficulties.<\/span><\/span><\/p><\/blockquote>\n

Fernando Figueroa MD<\/span><\/span><\/strong> , professor of medicine at the University of the Andes, Chile\u00a0<\/span><\/span><\/cite><\/p>\n

During the study, <\/span><\/span>stem cells<\/span><\/span><\/a> were applied to the <\/span>cardiac muscle via intravenous infusion. <\/span>The results suggest that patients experienced clear improvements in cardiac muscle function and quality of life. <\/span>The test revealed sustained and significant improvements in the heart’s ability to pump blood – with no negative side effects. <\/span>During organ transplants and blood transfusions it is common for patients to suffer from immune complications, but this study did not report any complications.<\/span><\/span><\/p>\n

As a rule, drug-based treatments to control heart failure may be insufficient, and patients often have to move towards more invasive therapies, such as mechanical ventricular assist devices and heart transplantation<\/span><\/span><\/p><\/blockquote>\n

Jorge Bartolucci MD<\/span><\/span><\/strong> , Cardiologist at Cells for Cells and Professor at the University of Los Andes\u00a0<\/span><\/span><\/cite><\/p>\n

Umbilical cord stem cells are readily available without ethical objections. <\/span>This makes them an attractive alternative to bone marrow or embryonic stem cells. <\/span>Heart failure affects an estimated 37 million people worldwide and 50% of patients will die within five years of diagnosis. <\/span>This new study brings hope about the possibility of effective treatment.<\/span><\/span><\/p>\n

Read more on this topic at <\/span><\/span>American Heart Association<\/span><\/span><\/a> or <\/span><\/span>@HeartNews<\/span><\/span><\/a> or on Twitter.<\/span><\/span><\/p>\n

\n